Q: Wondering if you think this is a good opportunity to purchase ZTS as the clear industry leader in the animal health space after missing quarterly estimates. Or is the business in decline? Is PAHC the better buy right now based on valuations and growth going forward?
You can view 3 more answers this month. Sign up for a free trial for unlimited access.
Investment Q&A
Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.
Q: ALT: US What is your impression on this clinical stage bio pharmaceutical company ?
Do these small bio pharma companies have any chance of being a take out target from the larger player?
What is your risk assessment on this company
From 1-10 . 1 being high risk . 10 being low risk.
Thanks
Cal .
Do these small bio pharma companies have any chance of being a take out target from the larger player?
What is your risk assessment on this company
From 1-10 . 1 being high risk . 10 being low risk.
Thanks
Cal .
-
Microsoft Corporation (MSFT $507.23)
-
Zoetis Inc. Class A (ZTS $156.62)
-
Novo Nordisk A/S (NVO $56.98)
Q: I am seeking single digit capital gain over the next 2 years which of the 3 companies would you buy. and why. what is the biggest risk for ZTS. is the competition from LLY now baked in to the price ofNVO thanks Richard
Q: I am interested in starting a position here. The recent acquisition they made should add to growth... unless it is not going well? Also I feel like I am motivated by its low price (opposite of momentum strategy). Any good news with the Q4 and LNTH should move higher. Your thoughts please.
Q: What is your current opinion of this stock..... do you think it will do well in the next 2 years?
Q: Hello,
Why Editas stock go up today?
Thanks!
Why Editas stock go up today?
Thanks!
Q: Hi 5i,
What do you think of WST? It had a big correction.
Thank you
What do you think of WST? It had a big correction.
Thank you
Q: Is it time to let it go? Thanks
-
iShares Biotechnology ETF (IBB $139.84)
-
SPDR Biotech ETF (XBI $90.92)
-
Natera Inc. (NTRA $165.60)
-
ARK Genomic Revolution ETF (ARKG $25.24)
-
Catalyst Pharmaceuticals Inc. (CPRX $21.08)
Q: It looks like biotech stocks are on a tear, especially those that may benefit from AI. Do you have any names that you might recommend? I'm considering the Arkg fund but I don't quite trust Cathy Woods after losing money on the Arkk fund in 2021. Thank you,
Jason
Jason
Q: HIMS
Why the strength in Shares. What is RFK Jr stance on these weight losing companies . 50 % of Americans are overweight and this effects their health , Please comment on other LLY and NOVO Thank you RAK
Why the strength in Shares. What is RFK Jr stance on these weight losing companies . 50 % of Americans are overweight and this effects their health , Please comment on other LLY and NOVO Thank you RAK
-
Abbott Laboratories (ABT $132.59)
-
Eli Lilly and Company (LLY $711.68)
-
Pfizer Inc. (PFE $25.88)
-
Novo Nordisk A/S (NVO $56.98)
-
Moderna Inc. (MRNA $27.12)
Q: Hello,
Given the current price levels of both MRNA and PFE would this be a good time to take position in either one of those? If so which one would you recommend.
Thank you!
Given the current price levels of both MRNA and PFE would this be a good time to take position in either one of those? If so which one would you recommend.
Thank you!
Q: May I please get your thoughts on this company? I like their new non-opioid pain killer that was just approved by the FDA for a strong growth prospect. I am curious what you think about the existing business and the fundamentals/financials of the company. Thanks.
Q: DR Medical Facilities Corp.
What's your opinion on their "Dutch Auction?"
Forecast for the future of this stock, is it worth holding or time to sell?
Thank you.
What's your opinion on their "Dutch Auction?"
Forecast for the future of this stock, is it worth holding or time to sell?
Thank you.
Q: Thank you for your prompt answer; I was not sure whether the company consistently advised much lower prospects or whether there was some seasonality to their earnings. My take is that corporate earnings prospects do need to be as accurate as possible and is an appropriate response, and guidance, to shareholders investment.
Q: Can you comment on earnings and prospects please
Q: Earnings are up but outlook is down - possibly because of Kennedy appointment - would appreciate your comment as I do not seem able to access their earnings statement recording.
Q: Your thoughts on the most recent results for MCK would be appreciated. Thanks
Ian
Ian
-
iShares Global Healthcare ETF (IXJ $88.31)
-
Health Care Select Sector SPDR (XLV $138.17)
-
Vanguard Health Care ETF (VHT $256.46)
Q: Hello, can you please provide your opinion of IXJ and whether you think it is a buy at its current price.
Also, if there is a different US healthcare ETF that you think is better please provide advise why and what you think a good entry price is.
Thanks as always for the advice.
Paula
Also, if there is a different US healthcare ETF that you think is better please provide advise why and what you think a good entry price is.
Thanks as always for the advice.
Paula
Q: Hi 5i,
Would you please provide your opinion on Vertex Pharmaceuticals (VRTX) as a 3-5 year investment.
Does their recent announcement related to an FDA approved non-addictive, non-opioid painkiller have promise?
If so, what would be the longer term implications for the company?
Thanks.
Would you please provide your opinion on Vertex Pharmaceuticals (VRTX) as a 3-5 year investment.
Does their recent announcement related to an FDA approved non-addictive, non-opioid painkiller have promise?
If so, what would be the longer term implications for the company?
Thanks.
Q: Would welcome your analysis on this small cap- it has recently received some positive reports. It appears to be cash flow positive and has a new drug approval.